Genezen News & Resources
Keep up to date with the latest news at Genezen, and explore our expert content around molecular biology news and insights.
LVV Approaches to Pseudotyping and Plasmid…
As cell and gene therapies (C>s) continue to provide unprecedented advancements...
Read moreGenezen Announces the Appointment of Steven…
BOSTON, MA and FISHERS, IN. – March 13, 2023 – Genezen,...
Read moreOmar Lamm on Developments in Pharma…
An interview with Omar Lamm discussing his career in pharma, where...
Read moreFeatured
Understanding the requirements of viral vector…
Analytical method development, qualification, and validation are an integral part of...
Read more4 factors driving the trend towards…
The cell and gene therapy (C>) space is expanding rapidly. With...
Read moreDownstream Process Development for Lentiviral Vectors…
Lentiviral vectors (LVV) are commonly used as an efficient and safe...
Read moreGet insights like this directly to your inbox
Sign up to our newsletter
Our solutions
From Process Development, Testing, GMP Vector Manufacturing to Cell Manufacturing
Our team offers the guidance, expertise, technology, and manufacturing capacity to help bring your viral vector therapy to market with precision and speed.
